M.D., Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology
As Senior Vice President and Chief Medical Officer of the American Society of Clinical Oncology, Dr. Schilsky is involved in professional and patient education, quality improvement, policy and advocacy, communications, clinical research and development of CancerLinQ, ASCO’s rapid learning system for oncology. Prior to joining ASCO, Dr. Schilsky was a faculty member at the University of Chicago from 1984-2012. He served as Director of the University of Chicago Cancer Research Center (1991-99), as Associate Dean for Clinical Research (1999-2007) and as Chief of the Section of Hematology-Oncology (2009-2012). He presently serves as a member of the Board of Directors of the Reagan-Udall Foundation for the FDA, of Friends of Cancer Research and of the National Coalition for Cancer Research, and as a member of the National Cancer Policy Forum of the National Academy of Medicine. Dr. Schilsky has served as a member of the Board of Directors of ASCO and of the Conquer Cancer Foundation of ASCO and as ASCO President 2008-2009.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: The increase in genetic tumor sequencing technology has led to its incorporation as part of clinical practice. To develop a more routine personalized medicine approach implementing precision medicine in clinical practice requires overcoming barriers and uncertainties. This session focuses on the issues encountered as clinicians try to put precision medicine into practice.